Dementia with Lewy bodies (DLB) and Parkinson’s disease dementia (PDD) are two neurodegenerative cause of dementia, in which patients are generally treated with Cholinesterase inhibitors. This is an NIHR Health Technology Assessment funded international multi-centre …
Combining Memantine and Cholinesterase inhibitors in Lewy body dementia treatment trial (COBALT)
read more